MedTrace Logo

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

NCT01467349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2013-02-11

No results posted yet for this study

Summary

This will be a retrospective analysis of efficacy, safety and tolerability of raltegravir as part of an optimized therapy in a clinical setting.

Follow-up is calculated from the treatment initiation (with or without raltegravir) up to the date of discontinuation of the considered regimen or the date of last visit or the date of lost to follow-up, whichever came first.

The Aim of the study is to evaluate the efficacy and safety of raltegravir-containing regimens in a urban clinic setting.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Ospedale San Raffaele

    collaborator OTHER

  • Università Vita-Salute San Raffaele

    lead OTHER

Principal Investigators

  • Massimo Clementi, Prof. · Università Vita-Salute

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-10-31
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01467349 on ClinicalTrials.gov